Abstract
A 26-year-old woman (G2P1) is referred to you for consultation. She is in her second month of pregnancy and on valproic acid 1000 mg twice daily for her medically stable Juvenile Myoclonic Epilepsy. She has not had any seizure recurrences in the past year. Would you lower valproic acid; discontinue it or switch to another seizure medication during her current pregnancy? If you would switch her seizure medication, what would you switch to and how do you manage her epilepsy during this pregnancy?.
| Original language | English |
|---|---|
| Title of host publication | Controversies in Caring for Women with Epilepsy |
| Subtitle of host publication | Sorting Through the Evidence |
| Publisher | Springer International Publishing |
| Pages | 115-123 |
| Number of pages | 9 |
| ISBN (Electronic) | 9783319291703 |
| ISBN (Print) | 9783319291680 |
| DOIs | |
| State | Published - 1 Jan 2016 |
| Externally published | Yes |
Keywords
- Anticonvulsant
- Antiepileptic
- Antiepileptic drugs
- Birth outcome
- Cognitive development
- Congenital malformations
- Depakote
- Epilepsy
- Juvenile
- Lamotrigine
- Levetiracetam
- Malformation
- Myoclonic
- Pregnancy
- Teratogenicity
- Topiramate
- Valproate
- Valproic acid